Trial Profile

Can Treatment With Low Molecular Weight Heparin During Pregnancy With Intrauterine Growth Restriction Increase Birth Weight?

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 22 Aug 2016

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Tinzaparin sodium (Primary)
Indications Embolism and thrombosis; Fetal growth retardation
Focus Therapeutic Use

Most Recent Events

15 Jul 2016 Status changed from recruiting to completed.
18 May 2016 Planned primary completion date changed from 1 Sep 2016 to 1 Aug 2016.
08 Jun 2015 Planned End Date changed from 1 Nov 2013 to 1 Sep 2016 as reported by ClinicalTrials.gov record.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com